Literature DB >> 22011542

A clinical prediction rule for fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection.

Pinyo Rattanaumpawan1, Pam Tolomeo, Warren B Bilker, Ebbing Lautenbach.   

Abstract

Data from a case-control study were used to derive and internally validate a prediction rule for identifying fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection. This prediction rule has an excellent sensitivity and specificity (C-statistic, 0.816). External validation is necessary before implementing this rule to optimize empirical antibiotic use in clinical practice.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22011542      PMCID： PMC3228239          DOI： 10.1086/662379

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  5 in total

1.  A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance.

Authors:  Carlos Bantar; Beatriz Sartori; Eduardo Vesco; Claudia Heft; Mariano Saúl; Francisco Salamone; María Eugenia Oliva
Journal:  Clin Infect Dis       Date:  2003-07-09       Impact factor: 9.079

2.  Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections.

Authors:  P Rattanaumpawan; P Tolomeo; W B Bilker; N O Fishman; E Lautenbach
Journal:  J Hosp Infect       Date:  2010-12       Impact factor: 3.926

3.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

4.  Resistant gram-negative bacilli: A neglected healthcare crisis?

Authors:  Ebbing Lautenbach; Ron E Polk
Journal:  Am J Health Syst Pharm       Date:  2007-12-01       Impact factor: 2.637

5.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918
  5 in total
  1 in total

Review 1.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.